Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Mochida Pharmaceutical patents new GRP40 receptor agonists

Nov. 29, 2012

Safety and pharmacokinetic phase I data reported for MGL-3196

Nov. 29, 2012

Phase I and II data reveal efficacy of AMG-145

Nov. 29, 2012

GW Pharmaceuticals identifies novel oral cannabinoid candidate for type 2 diabetes

Nov. 29, 2012

EMA recommends granting orphan status to Aspireo's somatoprim

Nov. 26, 2012

Arena Pharmaceuticals divulges novel GRP119 receptor agonists

Nov. 26, 2012

Study of alpha-1-antitrypsin drug shows efficacy and safety in type 1 diabetes

Nov. 23, 2012

GSK-1292263 markedly reduces lipids in nondiabetic subjects

Nov. 23, 2012

Niacin analogue ARI-3037-MO evaluated in healthy subjects

Nov. 23, 2012

Researchers at Pfizer present new acetyl-CoA carboxylase inhibitors

Nov. 22, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...